Investor Relations
Investor Highlights
Fluence is a leader in the decentralized water, wastewater and reuse treatment markets, with its Smart Products Solutions, including Aspiral™, NIROBOX™ and SUBRE. In addition to rapid delivery and commissioning of decentralized solutions to meet a broad range of needs, Fluence offers ongoing operation and maintenance support, as well as water as a service and other recurring revenue solutions. Fluence has a broad international footprint and focuses on high growth markets including China, the Middle East, Southeast Asia, and North America.
IR CONTACTS
Melanie Leydin
Company Secretary
+61 417 663 119 | Email
Andrew Angus
Director, Overland Advisers
+61 402 823 757 | Email
Investor Resources
Governance
- 2023 Statement of Governance
- 2023 ASX Appendix 4G
- Continuous Disclosure Policy
- Audit and Risk Committee Charter
- Board Charter
- Code of Conduct
- Diversity Policy
- Remuneration and Nomination Committee Charter
- Share Trade Policy
- Shareholder Communication Policy
- Modern Slavery Policy
- Whistleblower Policy
- Anti-Bribery and Corruption Policy
Financial Reports
2022
2021
- 2021 Annual Report
- Quarterly Activities Report December 2021
- Business Update December 2021
- Appendix 4C December 2021
- Quarterly Activities Report October 2021
- Business Update October 2021
- Appendix 4C October 2021
- Quarterly Activities Report July 2021
- Business Update July 2021
- Appendix 4C July 2021
- Quarterly Activities Report March 2021
- Appendix 4C March 2021
- Business Update March 2021
2020
- 2020 Annual Report
- 2020 Audited Financial Statements
- Quarterly Activities Report December 2020
- Appendix 4C Q4 December 2020
- Business Update December 2020
- Business Update September 2020 Call – Management Prepared Remarks
- Appendix 4C Q3 September 2020
- ASX Appendix 4C Business Update September 2020
- ASX Cover Page
- H1 2020 full set of financials
- H1 2020 Fluence Corporation Results Deck
- Business Update June 2020 Call – Management Prepared Remarks
- Quarterly Activities Report June 2020
- Appendix 4C Q2 June 2020
- Business Update April 2020 Call – Management Prepared Remarks
- Appendix 4C Q1 March 2020
- ASX Appendix 4C Business Update and Presentation March 2020
2019
- 2019 Annual Report
- 2019 Audited Financial Statements
- Business Update December 2019 Call – Management Prepared Remarks
- Appendix 4C Q4 December 2019
- ASX Appendix 4C Business Update December 2019
- ASX Appendix 3B, December 2019
- Business Update September 2019 Call – Management Prepared Remarks
- ASX Appendix 4C Business Update September 2019
- Appendix 4C Q3 September 2019
- Appendix 4D Half Year Report, June 2019
- Appendix 4C Q2 June 2019
- ASX Appendix 4C Business Update June 2019
- Business Update June 2019 Call - Management Prepared Remarks
- Appendix 4C Q1 March 2019
- ASX Appendix 4C Business Update March 2019
2018
- Annual Report 2018
- 2018 Audited Financial Statement
- ASX Appendix 4C Business Update December 2018
- Appendix 4C Q4 December 2018
- ASX Appendix 3B, November 2018
- ASX Appendix 4C Business Update September 2018
- Appendix 4C Q3 September 2018
- Appendix 4D Half Year Report, June 2018
- ASX Appendix 4C Business Update June 2018
- Appendix 4C Q2 June 2018
- ASX Appendix 4C Business Update March 2018
- Appendix 4C Q1 March 2018
- Appendix 4E Q1 February 2018
- ASX Appendix 4E Business Update
2017
- Annual Report 2017
- 2017 Audited Financial Statements
- Appendix 4C Q4 December 2017
- ASX Appendix 4C Year End Business Update December 2017
- Appendix 4C Q3 September 2017
- ASX Appendix 4C Business Update September 2017
- Appendix 4D Half Year Report June 2017
- Appendix 4C Q2 June 2017
- ASX Appendix 4C Statement of Cash Flows June 2017
2016
Recent Events
Fluence Reaches Milestone With Over 300 MABR Plants
Fluence has surpassed more than 300 MABR plants sold worldwide. With capacities ranging from a cluster of homes to city-scale, the plants have a total treatment capacity for nearly 1 million people in 15 countries. Learn more about Fluence's MABR products.
